Top Growth Stocks for June 2023

12:50pm, Tuesday, 06'th Jun 2023
These are the growth stocks with the fastest EPS and revenue growth heading into June.
agilon health, inc. (NYSE:AGL ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lis
Agilon Health (AGL) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to break-even earnings per share a year ago.
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the follow
Growing patient volumes, admissions, health awareness and technological improvement in the first quarter are likely to have aided healthcare players like Humana (HUM), Viatris (VTRS), agilon health (A
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial res
agilon health hosted its 2023 investor day, with positive updates on new health system partnerships and favorable updates to 2026 targets. Post the investor day, I have further conviction on AGL's val
agilon health recently reported its Q4 2022 financial results. The firm provides value-based healthcare solutions to seniors in the United States.
agilon health, Inc. (NYSE:AGL ) Q4 2022 Results Conference Call March 1, 2022 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants S
Agilon (AGL) delivered earnings and revenue surprises of -75% and 3.52%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
AUSTIN, Texas--( BUSINESS WIRE )--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial r
I believe the current US healthcare setup is not ideal for stakeholders. The agilon health platform offers a compelling value proposition to stakeholders.
agilon health, inc. is unable to return back to previous highs, losing support and buying volume. This, despite a reasonably strong quarter of growth.
It's working toward speeding up the global transition to cleaner energy.
agilon health, inc. (NYSE:AGL ) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participant
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE